Your browser is no longer supported. Please, upgrade your browser.
Settings
VCYT Veracyte, Inc. daily Stock Chart
VCYT [NASD]
Veracyte, Inc.
Index- P/E- EPS (ttm)-0.80 Insider Own1.40% Shs Outstand34.23M Perf Week6.13%
Market Cap290.27M Forward P/E- EPS next Y-0.59 Insider Trans-11.94% Shs Float33.42M Perf Month7.21%
Income-25.60M PEG- EPS next Q-0.23 Inst Own94.20% Short Float1.98% Perf Quarter9.28%
Sales71.70M P/S4.05 EPS this Y16.10% Inst Trans0.60% Short Ratio6.85 Perf Half Y-7.52%
Book/sh1.41 P/B6.01 EPS next Y35.90% ROA-29.10% Target Price12.00 Perf Year17.29%
Cash/sh1.36 P/C6.24 EPS next 5Y- ROE-53.60% 52W Range5.82 - 9.71 Perf YTD9.56%
Dividend- P/FCF- EPS past 5Y-9.30% ROI-33.80% 52W High-12.66% Beta1.91
Dividend %- Quick Ratio5.50 Sales past 5Y89.80% Gross Margin63.50% 52W Low45.70% ATR0.32
Employees216 Current Ratio5.80 Sales Q/Q25.20% Oper. Margin-31.60% RSI (14)58.34 Volatility4.77% 3.99%
OptionableYes Debt/Eq0.53 EPS Q/Q46.60% Profit Margin-35.60% Rel Volume1.20 Prev Close8.30
ShortableYes LT Debt/Eq0.53 EarningsJul 31 AMC Payout- Avg Volume96.55K Price8.48
Recom1.30 SMA204.26% SMA504.52% SMA2004.92% Volume115,722 Change2.17%
Aug-31-17Resumed BTIG Research Buy $13
Nov-14-16Resumed Leerink Partners Outperform $12
Dec-18-15Initiated Cantor Fitzgerald Buy $13
Jun-11-15Reiterated Leerink Partners Outperform $11 → $13
Nov-26-13Initiated William Blair Outperform
Sep-19-17 08:03AM  Awareness Campaign Takes Lung Cancer Risk Head-On, Asking North Carolinians To Screen Together PR Newswire
08:00AM  Veracyte Launches Campaign to Save Lives through Early Screening for Lung Cancer Business Wire
Sep-18-17 10:07AM  5 MedTech Stocks to Pick for Stellar Returns Zacks
Sep-13-17 10:00AM  Veracyte to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire
Sep-11-17 09:31AM  5 Top-Ranked MedTech Growth Stocks for Solid Returns Zacks
Aug-24-17 10:00AM  Veracyte to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Business Wire
Aug-17-17 04:06PM  ETFs with exposure to Veracyte, Inc. : August 17, 2017 Capital Cube
Aug-12-17 07:30PM  Edited Transcript of VCYT earnings conference call or presentation 31-Jul-17 8:30pm GMT Thomson Reuters StreetEvents
04:41AM  Edited Transcript of VCYT earnings conference call or presentation 3-May-17 8:30pm GMT Thomson Reuters StreetEvents
01:00AM  Edited Transcript of VCYT earnings conference call or presentation 1-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
Aug-02-17 03:36PM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017 Capital Cube
Jul-31-17 09:17PM  Veracyte reports 2Q loss Associated Press
04:05PM  Veracyte Announces Second Quarter 2017 Financial Results Business Wire
11:00AM  Investor Network: Veracyte Inc. to Host Earnings Call ACCESSWIRE
08:30AM  Veracyte Announces Pivotal Clinical Validation Data for Afirma Genomic Sequencing Classifier Presented at World Congress on Thyroid Cancer Business Wire
Jul-26-17 08:35AM  Veracyte Announces Positive Data From Three Afirma Studies to Be Presented at World Congress on Thyroid Cancer Business Wire
Jun-27-17 08:05AM  Veracyte Announces Publication of Study Supporting the Development of Envisia Genomic Classifier for IPF in Annals of the American Thoracic Society PR Newswire
Jun-26-17 08:00AM  Veracyte Named a San Francisco Bay Area "Top Workplace" For Fourth Consecutive Year PR Newswire
Jun-01-17 01:00PM  Veracyte to Present at William Blair 2017 Growth Stock Conference PR Newswire
May-23-17 03:00PM  Veracyte Announces Clinical Validation Data Demonstrating Envisia Genomic Classifier's Performance in Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2017 PR Newswire
May-18-17 12:18PM  Veracyte Announces Anthem Coverage for the Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis PR Newswire +5.58%
May-11-17 08:30AM  Data Demonstrating Cost-Effectiveness of Veracyte's Percepta® Bronchial Genomic Classifier Published in "Journal of Thoracic Oncology" PR Newswire
May-10-17 08:00AM  Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017 PR Newswire
May-09-17 05:10PM  ETFs with exposure to Veracyte, Inc. : May 9, 2017 Capital Cube
May-08-17 11:11AM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017 Capital Cube -7.18%
08:00AM  Data Presented at AACE 2017 Annual Meeting Demonstrate Long-Term Clinical Utility Of Veracyte's Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis PR Newswire
May-04-17 04:05PM  Veracyte Announces Pivotal Clinical Validation Data for Next-Generation Afirma® Test To Help More Patients Avoid Unnecessary Surgery in Thyroid Cancer Diagnosis PR Newswire +5.49%
May-03-17 06:11PM  Veracyte reports 1Q loss Associated Press -5.66%
04:05PM  Veracyte Announces First Quarter 2017 Financial Results PR Newswire
Apr-26-17 08:00AM  Veracyte Announces Multiple Studies Demonstrating Powerful Results from Afirma® Classifiers To Be Presented at the AACE 2017 Annual Meeting PR Newswire +5.48%
Apr-19-17 04:30PM  Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017 PR Newswire
Apr-03-17 12:00PM  Multiple Studies Presented at ENDO 2017 Support Use of Veracyte's Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis PR Newswire
Mar-23-17 08:00AM  Veracyte Announces that Multiple Studies Supporting Clinical Utility of Its Afirma® Gene Expression Classifier To Be Presented at ENDO 2017 PR Newswire
Mar-08-17 12:04PM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017 Capital Cube
12:04PM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017
Mar-07-17 01:04PM  VERACYTE, INC. Financials
Mar-06-17 04:21PM  VERACYTE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-01-17 04:56PM  Veracyte reports 4Q loss Associated Press
04:29PM  VERACYTE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook PR Newswire
07:07AM  Q4 2016 Veracyte Inc Earnings Release - After Market Close
Feb-28-17 04:05PM  Veracyte Announces Executive Promotions PR Newswire
Feb-27-17 10:20AM  Veracyte Announces Publication of Data Demonstrating Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis PR Newswire
Feb-21-17 08:00AM  Veracyte Announces Ten New Blues Plan Coverage Policies for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis PR Newswire
Feb-15-17 08:00AM  Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017 PR Newswire
Feb-09-17 09:44AM  Quest Diagnostics Partners with Veracyte for Cancer Testing
Feb-08-17 08:00AM  Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics PR Newswire
Feb-06-17 08:00AM  Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier PR Newswire
Feb-02-17 08:00AM  Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference PR Newswire
Dec-22-16 02:20PM  ETFs with exposure to Veracyte, Inc. : December 22, 2016
Dec-15-16 08:45AM  4 Growth Stocks to Buy Amid Obamacare Repeal Talks
Dec-13-16 05:04PM  VERACYTE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:00AM  Veracyte Announces Appointment of Kevin K. Gordon and Other Changes to Its Board of Directors PR Newswire
Dec-12-16 05:57PM  Veracyte Inc (VCYT): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-28-16 12:07PM  Edited Transcript of VCYT earnings conference call or presentation 3-Nov-16 8:30pm GMT
Nov-23-16 04:24PM  VERACYTE, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Nov-22-16 07:00AM  Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma® Gene Expression Classifier in 2017 PR Newswire
Nov-21-16 04:36PM  VERACYTE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:00AM  Veracyte Appoints Keith Kennedy as Chief Financial Officer PR Newswire
Nov-15-16 08:00AM  Veracyte to Participate in Two Upcoming Investor Conferences PR Newswire
Nov-07-16 11:14AM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
Nov-03-16 05:49PM  Veracyte reports 3Q loss
04:52PM  VERACYTE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Veracyte Announces Third Quarter 2016 Financial Results PR Newswire
07:07AM  Q3 2016 Veracyte Inc Earnings Release - After Market Close
Nov-02-16 04:59PM  VERACYTE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -10.24%
08:00AM  Veracyte Announces Pricing of Public Offering of 5,000,000 Shares of Common Stock PR Newswire
Nov-01-16 05:07PM  VERACYTE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:12PM  Veracyte Announces Proposed Public Offering of Common Stock PR Newswire
Oct-26-16 04:30PM  New Data Show that Use of Percepta® Bronchial Genomic Classifier Reduces Surgeries and Other Costly Procedures in Lung Cancer Screening and Diagnosis PR Newswire
Oct-25-16 08:00AM  Veracyte Announces Launch of Envisia Genomic Classifier for Improved Diagnosis of Idiopathic Pulmonary Fibrosis at CHEST Annual Meeting 2016 PR Newswire
Oct-19-16 04:55PM  VERACYTE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Oct-18-16 11:19AM  ETFs with exposure to Veracyte, Inc. : October 18, 2016
Oct-17-16 05:30PM  Veracyte Releases Preliminary Third Quarter 2016 Financial Results PR Newswire
Oct-13-16 08:00AM  Data Demonstrating Clinical Value of Veracyte Genomic Tests for Use in Lung Cancer and IPF to Be Presented at CHEST Annual Meeting 2016 PR Newswire
Oct-03-16 05:20PM  VERACYTE, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Sep-30-16 07:00PM  Veracyte Releases Statement on CMS's Final 2017 Gapfill Rate for the Afirma® Gene Expression Classifier PR Newswire
Sep-23-16 11:45AM  Veracyte Presents Data Demonstrating Potential to Enhance Afirma® Gene Expression Classifier Using an RNA Sequencing Platform PR Newswire
Sep-15-16 04:05PM  Veracyte Secures Draft Medicare Local Coverage Determination for Percepta® Bronchial Genomic Classifier from Palmetto GBA PR Newswire
08:00AM  Veracyte Announces Data from Seven Afirma® Gene Expression Classifier Studies to Be Presented at the 86th Annual Meeting of the American Thyroid Association PR Newswire
Sep-08-16 07:30AM  Veracyte Achieves Major Medicare Coverage Milestone for the Percepta® Classifier to Improve Lung Cancer Diagnosis PR Newswire +15.81%
Aug-30-16 08:00AM  Veracyte to Present at Morgan Stanley Global Healthcare Conference PR Newswire
Aug-23-16 12:36PM  ETFs with exposure to Veracyte, Inc. : August 23, 2016
Aug-19-16 02:55PM  Edited Transcript of VCYT earnings conference call or presentation 3-Aug-16 8:30pm GMT
Aug-12-16 11:01AM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-03-16 06:43PM  Veracyte reports 2Q loss
04:46PM  VERACYTE, INC. Files SEC form 10-Q, Quarterly Report
04:31PM  VERACYTE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Veracyte Announces Second Quarter 2016 Financial Results PR Newswire
07:07AM  Q2 2016 Veracyte Inc Earnings Release - After Market Close
Aug-02-16 08:46AM  Medical Instrument Aug 3 Earnings Lineup: TEAR, GI & More
Jul-29-16 02:00PM  ETFs with exposure to Veracyte, Inc. : July 29, 2016
Jul-12-16 08:00AM  Veracyte to Host Conference Call and Webcast to Discuss Second Quarter 2016 Financial Results on Wednesday, August 3, 2016 PR Newswire
Jun-30-16 08:00AM  Veracyte to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference PR Newswire
Jun-27-16 07:30AM  Veracyte Named a San Francisco Bay Area 2016 "Top Workplace" PR Newswire
Jun-17-16 06:51PM  Veracyte Releases Statement on CMS's Final PAMA Rule PR Newswire
04:11PM  VERACYTE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-13-16 04:13PM  VERACYTE, INC. Files SEC form 8-K, Change in Directors or Principal Officers -5.69%
04:05PM  Veracyte Announces Resignation of Its Chief Financial Officer PR Newswire
Jun-10-16 09:45PM  Veracyte Statement on CMS's Preliminary Gapfill Rate for the Afirma® Gene Expression Classifier PR Newswire
Veracyte, Inc. operates as a molecular diagnostics company in the United States. The company uses genomic technology to resolve diagnostic ambiguity. It offers Afirma Thyroid FNA Analysis solution for use in thyroid cancer diagnosis; cytopathology testing services; and the Afirma Malignancy Classifiers to manage thyroid nodule patients. The company's products also include Percepta Bronchial Genomic Classifier solution for use in lung cancer screening and diagnosis; and Envisia Genomic Classifier solution for idiopathic pulmonary fibrosis. It sells its products through its product specialists, institutional channel managers, account managers, and clinical science specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JONES EVAN/ FADirectorAug 28Sale7.842,50019,600279,653Aug 29 04:07 PM
JONES EVAN/ FADirectorAug 25Sale7.8120,000156,200282,153Aug 29 04:07 PM
JONES EVAN/ FADirectorAug 24Sale7.8320,000156,600302,153Aug 25 04:16 PM
JONES EVAN/ FADirectorAug 23Sale7.9220,000158,400322,153Aug 25 04:16 PM
TREU JESSE IDirectorMay 16Sale8.082,22617,98620,504May 18 05:37 PM
Anderson Bonnie HChairman and CEOMar 21Option Exercise0.805,0004,00015,000Mar 23 04:28 PM
Anderson Bonnie HChairman and CEOMar 21Sale9.095,00045,43510,000Mar 23 04:28 PM